Rani Therapeutics (RANI)
0.61
-0.04 (6.15%)
Upcoming Events
Latest Headlines
Rani Therapeutics to Participate in the Chardan Healthcare Conference
October 13, 2026 4:05 PM - Globe NewsWire
H.C. Wainwright Reiterates Buy Rating on Rani Therapeutics (RANI)
October 6, 2026 7:07 AM - StreetInsider
FDA accepts Rani Therapeutics' RaniPill platform into emerging tech program
October 5, 2026 8:04 AM - StreetInsider
Rani Therapeutics Announces Acceptance into U.S. FDA's Emerging Technology Program (ETP)
October 5, 2026 8:00 AM - Globe NewsWire
Form 4 Rani Therapeutics Holdin For: Sep 27 Filed by: Imran Talat
September 29, 2026 4:43 PM - SEC Filing
Form 4 Rani Therapeutics Holdin For: Sep 27 Filed by: Javadi Alireza
September 29, 2026 4:36 PM - SEC Filing
H.C. Wainwright Reiterates Buy Rating on Rani Therapeutics (RANI)
August 21, 2026 6:59 AM - StreetInsider
Chardan Starts Rani Therapeutics (RANI) at Buy
August 18, 2026 7:12 AM - StreetInsider
Form SCHEDULE 13G/A Rani Therapeutics Holdin Filed by: RA CAPITAL MANAGEMENT, L.P.
August 14, 2026 4:50 PM - SEC Filing
Form 10-Q Rani Therapeutics Holdin For: Jun 30
August 13, 2026 4:18 PM - SEC Filing
Rani Therapeutics Holdings, Inc. (RANI) Tops Q2 EPS by 1c
August 13, 2026 4:15 PM - StreetInsider
Form 8-K Rani Therapeutics Holdin For: Aug 13
August 13, 2026 4:13 PM - SEC Filing
Rani Therapeutics Reports Second Quarter 2026 Financial Results; Provides Corporate Update
August 13, 2026 4:05 PM - Globe NewsWire
Rani Therapeutics to Participate in the Canaccord Genuity 46th Annual Growth Conference
August 10, 2026 8:00 AM - Globe NewsWire
Form 4 Rani Therapeutics Holdin For: Aug 03 Filed by: Gilson Michelle
August 4, 2026 8:52 PM - SEC Filing
Form 3 Rani Therapeutics Holdin For: Aug 01 Filed by: Gilson Michelle
August 4, 2026 8:49 PM - SEC Filing
Form 8-K Rani Therapeutics Holdin For: Aug 01
August 4, 2026 8:05 AM - SEC Filing
Rani Therapeutics names former Arcellx CFO to its board
August 4, 2026 8:00 AM - StreetInsider
Rani Therapeutics Appoints Michelle Gilson to Board of Directors
August 4, 2026 8:00 AM - Globe NewsWire
Form SCHEDULE 13G/A Rani Therapeutics Holdin Filed by: VANGUARD CAPITAL MANAGEMENT LLC
July 31, 2026 10:43 AM - SEC Filing
Form 4 Rani Therapeutics Holdin For: Jul 21 Filed by: IMRAN MIR A
July 23, 2026 4:10 PM - SEC Filing
Full Article List
